A study published in Science Advances reveals a new method that might enable cancer tumors to be treated by the patient’s own antibodies.
The team lead, Andrew Tsourkas, said “Much is yet to be done before this could be considered a practical clinical approach. But I hope at the very least this works stimulates new ideas in the way we think about personalized medicine.”
